Explore the full insider trade history of 디알젬, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 디알젬 has published 7 public disclosures. The latest transaction was disclosed on 21 November 2024 (Purchase). Among the most active insiders: 박정병. Every trade is openly available.
7
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
3 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.